Dechra Pharmaceuticals has now released their final results for the year ended 2017. Revenues increased when compared to last year with a £73.6M growth in North American sales and a £38.1M increase in European sales. Cost of sales also grew … Continue reading
Dechra Pharmaceuticals has now released their interim results for the year ending 2017. Revenues increased when compared to the first half of last year with a £37.4M growth in North American revenue (£25M attributable to the Brovel and Putney acquisitions) … Continue reading
Dechra Pharmaceuticals has now released its final results for the year ended 2016. Revenues increased when compared to last year with a £23.9M growth in North American revenue and a £20.2M increase in European revenue. Cost of inventories increased by … Continue reading